Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Span

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|March 4, 2015
Influence of inflammation on voriconazole metabolismM A Encalada Ventura, L F R Span, E R van den Heuvel, et al.
Cytometry|January 5, 2002
The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling techniqueL F R Span, A H M Pennings, G Vierwinden, et al.
European Journal of Haematology|August 30, 2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the NetherlandsWiro B Stam, Amy K O'Sullivan, Bart Rijnders, et al.
Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.
Leukemia & Lymphoma|October 30, 2004
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalitiesM M Van Rossum, N T M Verhaegen, M F Jonkman, et al.
Current Fungal Infection Reports|July 1, 2016
Therapeutic Drug Monitoring of Posaconazole: an UpdateBart G J Dekkers, Martijn Bakker, Kim C M van der Elst, et al.
BMJ Open|January 10, 2020
Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic reviewAnne-Grete Märtson, Martijn Bakker, Hans Blokzijl, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Bioavailability of voriconazole in hospitalised patientsAnette Veringa, Sanne Geling, Lambert F R Span, et al.
International Journal of Antimicrobial Agents|January 15, 2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective studyAnne-Grete Märtson, Anette Veringa, Martijn Bakker, et al.
Current Pharmaceutical Design|December 15, 2017
The Role of PET in Monitoring Therapy in Fungal InfectionsAlfred O Ankrah, Hans C Klein, Lambert F R Span, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|March 4, 2015
Influence of inflammation on voriconazole metabolismM A Encalada Ventura, L F R Span, E R van den Heuvel, et al.
Cytometry|January 5, 2002
The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling techniqueL F R Span, A H M Pennings, G Vierwinden, et al.
European Journal of Haematology|August 30, 2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the NetherlandsWiro B Stam, Amy K O'Sullivan, Bart Rijnders, et al.
Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.
Leukemia & Lymphoma|October 30, 2004
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalitiesM M Van Rossum, N T M Verhaegen, M F Jonkman, et al.
Current Fungal Infection Reports|July 1, 2016
Therapeutic Drug Monitoring of Posaconazole: an UpdateBart G J Dekkers, Martijn Bakker, Kim C M van der Elst, et al.
BMJ Open|January 10, 2020
Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic reviewAnne-Grete Märtson, Martijn Bakker, Hans Blokzijl, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Bioavailability of voriconazole in hospitalised patientsAnette Veringa, Sanne Geling, Lambert F R Span, et al.
International Journal of Antimicrobial Agents|January 15, 2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective studyAnne-Grete Märtson, Anette Veringa, Martijn Bakker, et al.
Current Pharmaceutical Design|December 15, 2017
The Role of PET in Monitoring Therapy in Fungal InfectionsAlfred O Ankrah, Hans C Klein, Lambert F R Span, et al.
Pageof 4